- Company Directors - A
- 14159, L.p.
Insider Trading History of 14159, L.p.
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by 14159, L.p. since 2012.
The trader's CIK number is 1551138.
At the time of the last reporting, 14159, L.p. was the Director of Beigene, Ltd.. (stock ticker symbol BGNE).
Also see all insider trading activities at Beigene, Ltd..
Note that in the past
14159, L.P. also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Genomic Health Inc (GHDX) by 14159, L.p.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | GHDX | 0 | $0 | 0 | $0 | 49,500 | $531,135 |
Yearly summary of insider trading at Beigene, Ltd. (BGNE) by 14159, L.p.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | BGNE | 1,760,495 | $56,335,840 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Incyte Corp (INCY) by 14159, L.p.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2013 | INCY | 0 | $0 | 0 | $0 | 30,000 | $133,200 |
Yearly summary of insider trading at Trimeris Inc (GEVA) by 14159, L.p.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2014 | GEVA | 375,000 | $39,656,250 | 0 | $0 | 0 | $0 |
| 2013 | GEVA | 1,909,720 | $100,323,991 | 0 | $0 | 0 | $0 |
| 2012 | GEVA | 886,000 | $36,503,200 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Seattle Genetics Inc /wa (SGEN) by 14159, L.p.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2014 | SGEN | 4,624,624 | $162,187,377 | 0 | $0 | 30,000 | $217,800 |
| 2013 | SGEN | 1,412,979 | $59,616,278 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Acadia Pharmaceuticals Inc (ACAD) by 14159, L.p.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | ACAD | 1,303,030 | $42,999,990 | 0 | $0 | 0 | $0 |
Insider trading activities at 6 companies by 14159, L.p.:
1. Genomic Health Inc (GHDX)
2. Beigene, Ltd. (BGNE)
3. Incyte Corp (INCY)
4. Trimeris Inc (GEVA)
5. Seattle Genetics Inc /wa (SGEN)
6. Acadia Pharmaceuticals Inc (ACAD)
Table 1. Insider trading of Genomic Health Inc (GHDX) by 14159, L.p.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-05-17 | GHDX | Option Ex | 49,500 | 10.73 | 531,135 |
Table 2. Insider trading of Beigene, Ltd. (BGNE) by 14159, L.p.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-11-18 | BGNE | Buy | 1,760,495 | 32.00 | 56,335,840 |
Table 3. Insider trading of Incyte Corp (INCY) by 14159, L.p.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2013-06-11 | INCY | Option Ex | 30,000 | 4.44 | 133,200 |
Table 4. Insider trading of Trimeris Inc (GEVA) by 14159, L.p.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2014-03-06 | GEVA | Buy | 375,000 | 105.75 | 39,656,250 |
| 2013-09-25 | GEVA | Buy | 1,050,000 | 56.63 | 59,461,500 |
| 2013-01-04 | GEVA | Buy | 859,720 | 47.53 | 40,862,491 |
| 2012-07-13 | GEVA | Buy | 886,000 | 41.20 | 36,503,200 |
Table 5. Insider trading of Seattle Genetics Inc /wa (SGEN) by 14159, L.p.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2014-12-08 | SGEN | Buy | 465,316 | 32.98 | 15,347,517 |
| 2014-12-09 | SGEN | Buy | 128,430 | 33.94 | 4,359,042 |
| 2014-12-10 | SGEN | Buy | 654,150 | 34.52 | 22,582,566 |
| 2014-11-07 | SGEN | Buy | 211,704 | 35.53 | 7,522,266 |
| 2014-11-06 | SGEN | Buy | 1,200,972 | 34.26 | 41,150,104 |
| 2014-11-10 | SGEN | Buy | 241,249 | 36.49 | 8,802,211 |
| 2014-06-12 | SGEN | Buy | 128,008 | 39.92 | 5,109,823 |
| 2014-06-13 | SGEN | Buy | 88,587 | 39.87 | 3,531,520 |
| 2014-06-05 | SGEN | Buy | 120,172 | 37.65 | 4,524,836 |
| 2014-06-06 | SGEN | Buy | 174,987 | 37.46 | 6,554,488 |
| 2014-06-09 | SGEN | Buy | 251,093 | 38.76 | 9,731,862 |
| 2014-06-02 | SGEN | Buy | 94,617 | 34.13 | 3,229,562 |
| 2014-06-03 | SGEN | Buy | 100,304 | 34.92 | 3,503,016 |
| 2014-06-04 | SGEN | Buy | 87,042 | 36.22 | 3,152,226 |
| 2014-05-15 | SGEN | Buy | 21,200 | 34.18 | 724,658 |
| 2014-05-16 | SGEN | Buy | 168,411 | 34.06 | 5,736,078 |
| 2014-05-14 | SGEN | Option Ex | 30,000 | 7.26 | 217,800 |
| 2013-05-07 | SGEN | Buy | 117,254 | 33.65 | 3,946,066 |
| 2013-05-08 | SGEN | Buy | 233,055 | 34.18 | 7,965,586 |
| 2013-05-09 | SGEN | Buy | 138,073 | 34.14 | 4,713,950 |
| 2013-12-13 | SGEN | Buy | 43,709 | 39.66 | 1,733,280 |
| 2013-12-12 | SGEN | Buy | 284,610 | 39.59 | 11,267,140 |
| 2013-12-16 | SGEN | Buy | 78,759 | 39.92 | 3,143,823 |
| 2013-12-04 | SGEN | Buy | 270,795 | 43.23 | 11,705,926 |
| 2013-12-05 | SGEN | Buy | 365,676 | 44.01 | 16,092,303 |
| 2013-12-03 | SGEN | Buy | 369,430 | 42.43 | 15,673,806 |
Table 6. Insider trading of Acadia Pharmaceuticals Inc (ACAD) by 14159, L.p.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-08-10 | ACAD | Buy | 1,303,030 | 33.00 | 42,999,990 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by 14159, L.p.
(Director of Beigene, Ltd. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.